Controlled Release Cardiovascular Therapeutics


Sustained Release Injectables  Controlled Release Cardiovascular Therapeutics • CRT322K • May 2022  US$3,850


 

 

The prevalence and incidence of cardiovascular conditions in developed economies continue to increase, creating challenges and opportunities for cardiovascular drug developers. While the vast majority of drugs for treating cardiovascular conditions are oral immediate release products, issues related to drug safety and patient compliance have focused attention on formulations that can improve drug safety profiles and reduce dosing frequency. Important treatment segments for controlled release cardiovascular drugs include angina, hypertension, arrhythmias, cholesterol, and peripheral artery disease. Important growth factors for controlled release cardiovascular drugs include evolving patient demographics, environmental and lifestyle causative factors, increased public awareness of cardiovascular conditions and their associated morbidities, and expanded patient access to cardiovascular treatment services.

sustained release injectables

 

 
 
 
 
     
Order Online
 
 

 

Controlled Release Cardiovascular Therapeutics – What You Will Learn

• Analyzes and evaluates controlled release cardiovascular drug products and assesses the market potential for existing and probable future products
• Analyzes product strategies, technologies and market development issues
• Provides detailed analysis of cardiovascular market segments, market demographics, and therapeutic strategies
• Profiles market sector companies, their product development activities, business strategies, and corporate alliances and affiliations
• Evaluates the impact of economic, technology, and regulatory factors on cardiovascular drug markets

 

Summary of Contents 

Controlled Release Cardiovascular Therapeutics
Executive Summary
Cardiovascular Therapeutics – Market Dynamics
The Cardiovascular Drug Landscape
Unmet Needs in Cardiovascular Clinical Treatment
Cardiovascular Drug Demand Drivers
Demographic Shifts
Evolving Drug Formulation Technology
Managed Care Initiatives
Growth in Self Administration
Modified Release Technologies
Oral
Advanced Film Coating Systems
Bead Systems
Bi-layer Tablets
Tri-layer Tablets
Microtablets
Transdermal
Cardiovascular Controlled Release Product Analysis
Cardiovascular Drug Commercialization Factors
Cardiovascular Segments for CR Therapeutics
Angina
Cholesterol Management
Heart Rhythm
Hypertension
Peripheral Artery Disease
Market Factors
Regulations and Approvals
US (FDA)
EU (EMEA)
Japan (PMDA)
Australia (TGA)
Managed Care and Healthcare Economics
Sector Participant Company Profiles